{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:59:45Z","timestamp":1774450785040,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ejca.2019.01.106","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T20:52:40Z","timestamp":1552596760000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1989-4553","authenticated-orcid":false,"given":"Manfred P.","family":"Lutz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Zalcberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Ducreux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Adenis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Allum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Aust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1964-1006","authenticated-orcid":false,"given":"Fatima","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike I.","family":"Grabsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8475-5459","authenticated-orcid":false,"given":"Pierre","family":"Laurent-Puig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8591-9339","authenticated-orcid":false,"given":"Florian","family":"Lordick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"M\u00f6hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"M\u00f6nig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radka","family":"Obermannova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Piessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Riddell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"R\u00f6cken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Roviello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul Magnus","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Seewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"van Cutsem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Dorothea","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Otto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2019.01.106_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.critrevonc.2017.12.019","article-title":"ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer","volume":"122","author":"Allum","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejca.2019.01.106_bib2","doi-asserted-by":"crossref","first-page":"17036","DOI":"10.1038\/nrdp.2017.36","article-title":"Gastric adenocarcinoma","volume":"3","author":"Ajani","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"7517","key":"10.1016\/j.ejca.2019.01.106_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Cancer Genome Atlas Research N","year":"2014","journal-title":"Nature"},{"issue":"7636","key":"10.1016\/j.ejca.2019.01.106_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature20805","article-title":"Integrated genomic characterization of oesophageal carcinoma","volume":"541","author":"Cancer Genome Atlas Research N","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejca.2019.01.106_bib5","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/S1470-2045(14)71016-2","article-title":"Familial gastric cancer: genetic susceptibility, pathology, and implications for management","volume":"16","author":"Oliveira","year":"2015","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2019.01.106_bib6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ajhg.2016.03.001","article-title":"Point mutations in Exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant","volume":"98","author":"Li","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.ejca.2019.01.106_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/jmedgenet-2015-103094","article-title":"Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers","volume":"52","author":"van der Post","year":"2015","journal-title":"J Med Genet"},{"issue":"11","key":"10.1016\/j.ejca.2019.01.106_bib8","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1046\/j.1365-2168.1998.00940.x","article-title":"Classification of adenocarcinoma of the oesophagogastric junction","volume":"85","author":"Siewert","year":"1998","journal-title":"Br J Surg"},{"issue":"suppl 5","key":"10.1016\/j.ejca.2019.01.106_bib9","doi-asserted-by":"crossref","first-page":"v50","DOI":"10.1093\/annonc\/mdw329","article-title":"Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Lordick","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2019.01.106_bib10","series-title":"NCCN Clinical Practice Guidelines in Oncology: Gastric Cancer [Version 5.2017]","year":"2017"},{"key":"10.1016\/j.ejca.2019.01.106_bib11","series-title":"NCCN Clinical Practice Guidelines: Esophageal and Esophagogastric Junction Cancers [version 4.2017]","year":"2017"},{"issue":"4","key":"10.1016\/j.ejca.2019.01.106_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1055\/s-0031-1273201","article-title":"German S3-guideline \u201cDiagnosis and treatment of esophagogastric cancer\u201d","volume":"49","author":"Moehler","year":"2011","journal-title":"Z Gastroenterol"},{"issue":"5","key":"10.1016\/j.ejca.2019.01.106_bib13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ejso.2013.09.020","article-title":"Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"40","author":"Waddell","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2019.01.106_bib14","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.ejca.2012.07.029","article-title":"Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer","volume":"48","author":"Lutz","year":"2012","journal-title":"Eur J Cancer"},{"issue":"suppl 5","key":"10.1016\/j.ejca.2019.01.106_bib15","doi-asserted-by":"crossref","first-page":"v38","DOI":"10.1093\/annonc\/mdw350","article-title":"Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Smyth","year":"2016","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2019.01.106_bib16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrclinonc.2016.15","article-title":"Clinical impact of tumour biology in the management of gastroesophageal cancer","volume":"13","author":"Lordick","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"1027","key":"10.1016\/j.ejca.2019.01.106_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/pgmj.2010.101832","article-title":"Quality control in upper gastrointestinal endoscopy: detection rates of gastric cancer in Oxford 2005\u20132008","volume":"87","author":"Vradelis","year":"2011","journal-title":"Postgrad Med J"},{"issue":"2","key":"10.1016\/j.ejca.2019.01.106_bib18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10120-015-0502-3","article-title":"Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer","volume":"19","author":"Tominaga","year":"2016","journal-title":"Gastric Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2019.01.106_bib19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2016.69.4836","article-title":"HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology","volume":"35","author":"Bartley","year":"2017","journal-title":"J Clin Oncol"},{"issue":"30","key":"10.1016\/j.ejca.2019.01.106_bib20","doi-asserted-by":"crossref","first-page":"e4196","DOI":"10.1097\/MD.0000000000004196","article-title":"Understanding the diagnostic yield of current endoscopic biopsy for gastric neoplasm: A prospective single-center analysis based on tumor characteristics stratified by biopsy number and site","volume":"95","author":"Kwack","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.ejca.2019.01.106_bib21","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/MNM.0000000000000137","article-title":"Incremental value of 18F-FDG PET\/CT in therapeutic decision-making of potentially curable esophageal adenocarcinoma","volume":"35","author":"Purandare","year":"2014","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1016\/j.ejca.2019.01.106_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejso.2016.08.020","article-title":"18)FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma","volume":"43","author":"Lehmann","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2019.01.106_bib23","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1470-2045(18)30132-3","article-title":"Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial","volume":"19","author":"Cats","year":"2018","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2019.01.106_bib24","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jamaoncol.2016.6762","article-title":"Mismatch repair deficiency, microsatellite instability, and survival: an exploratory analysis of the medical research council adjuvant gastric infusional chemotherapy (MAGIC) trial","volume":"3","author":"Smyth","year":"2017","journal-title":"JAMA Oncol"},{"issue":"suppl_3","key":"10.1016\/j.ejca.2019.01.106_bib25","volume":"28","author":"Al-Batran","year":"2017","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2019.01.106_bib26","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaoncol.2017.0515","article-title":"Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial","volume":"3","author":"Al-Batran","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2019.01.106_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejca.2019.01.106_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-018-0868-0","article-title":"Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma","volume":"22","author":"Mariette","year":"2019","journal-title":"Gastric Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2019.01.106_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/annonc\/mdw560","article-title":"Multimodality treatment for esophageal adenocarcinoma: multi-center propensity-score matched study","volume":"28","author":"Markar","year":"2017","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2019.01.106_bib30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/annonc\/mdw644","article-title":"What is the optimal neoadjuvant treatment for locally advanced oesophageal adenocarcinoma?","volume":"28","author":"Mariette","year":"2017","journal-title":"Ann Oncol"},{"issue":"13","key":"10.1016\/j.ejca.2019.01.106_bib31","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","article-title":"Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial","volume":"29","author":"Ychou","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2019.01.106_bib32","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"issue":"22","key":"10.1016\/j.ejca.2019.01.106_bib33","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491930156X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491930156X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:23:17Z","timestamp":1760732597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980491930156X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":33,"alternative-id":["S095980491930156X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2019.01.106","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2019.01.106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}